Back to MYL Stock Lookup

MYL – Analyst PT Change

Feb 28, 2014 09:02 AM Mylan (MYL) Will Have $3B in 'Firepower' by Year-End, Says Goldman Sachs
Jan 21, 2014 01:15 PM U.S. Large Cap and Specialty Pharma Q4 Previewed at UBS (PFE) (ACT) (MYL)
Nov 25, 2013 12:42 PM Mylan (MYL) Target Raised to $50 at Leerink Swann
Sep 12, 2013 01:28 PM Mylan (MYL) Target Raised to $46 at Goldman
Sep 10, 2013 07:18 AM Bernstein Upgrades Mylan (MYL) to Outperform
Nov 28, 2012 09:03 AM Canaccord Genuity Boosts Target on Mylan (MYL), Answers 5 Key Questions
Jul 27, 2012 02:47 PM Canaccord Genuity Maintains a 'Hold' on Mylan (MYL); Raising PT on Solid Q2
Jun 26, 2012 11:05 AM UBS Defends Momenta Pharmaceuticals (NASDAQ: MNTA); Negative News Largely In Stock
May 11, 2012 12:37 PM Goldman Sachs Sees Mylan (MYL) as a Strong Takeover Target
Apr 9, 2012 02:10 PM Barclays on U.S. Specialty Pharmaceuticals: Model Adjustments on MYL, PRX, TEVA, & WCRX
Feb 22, 2012 10:08 AM Canaccord Genuity Maintains a 'Hold' on Mylan (MYL); Analyst Day Big on Detail, Small on Guidance Surprise
Feb 14, 2012 07:17 AM Goldman Sachs Upgrades Mylan (MYL) to Buy, Sees Earnings Revised Higher

Back to MYL Stock Lookup